Deutsche Bank
SPRB

Deutsche Bank’s Spruce Biosciences SPRB Stock Holding History

Deutsche Bank’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Buy
+2,652
New +$148K ﹤0.01% 3388
2022
Q2 		– Sell
-164
Closed -$24K – 4361
2022
Q1 		$24K Buy
164
+94
+134% +$17.5K ﹤0.01% 4031
2021
Q4 		$24K Buy
70
+3
+4% +$893 ﹤0.01% 4109
2021
Q3 		$30K Sell
67
-2
-3% -$1.26K ﹤0.01% 4193
2021
Q2 		$58K Buy
69
+10
+17% +$10.7K ﹤0.01% 4278
2021
Q1 		$74K Sell
59
-6
-9% -$9.21K ﹤0.01% 4123
2020
Q4 		$119K Buy
+65
New +$108K ﹤0.01% 3753

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Deutsche Bank's SPRB Position: Q2 2026 in Review

Deutsche Bank opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 2,652 shares worth $143K. The stake represents ﹤0.01% of the portfolio and ranks #3388 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in SPRB as recently as Q1 2022.

Deutsche Bank first reported a position in SPRB in Q4 2020 and has held it in 7 quarters since. 63 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Deutsche Bank held 2,652 shares of Spruce Biosciences worth $143K as of Q2 2026.
  • Spruce Biosciences was a new Deutsche Bank position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3388 holding.
  • Deutsche Bank first reported a position in Spruce Biosciences in Q4 2020 and has held it in 7 quarters since.
  • 63 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.